Peter Navarro, an economist and former White House trade adviser, is heading to trial with a gutted defense and growing legal bills. Navarro is facing civil charges over his role in the Trump administration’s attempt to block the sale of a failed California medical device company.
Navarro has faced multiple lawsuits for his role in the attempted takeover of Visium Technologies, which was put on administrative hold in December of 2017 following a whistleblower complaint. He has filed a motion to dismiss those charges, claiming that he was acting in the public’s best interest as a White House employee.
Meanwhile, the suit against him has been whittled down to a few claims. His legal team, which has seen a significant reduction since the case began, is running out of money and facing a potentially costly trial.
Navarro has publicly maintained his innocence with respect to the alleged wrongdoing. But the case against him has certainly taken a toll, both financially and reputationally.
